XML 18 R4.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2Close
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Condensed Consolidated Statements of Operations and Comprehensive Loss    
Grant revenue $ 380,569   Close
Operating expenses:    
Research and development 1,600,373 $ 1,256,542
General and administrative 1,929,866 3,365,961
Total operating expenses 3,530,239 4,622,503 Close
Loss from operations (3,149,670) (4,622,503) Close
Other income (expense):    
Interest income, net 283,403 256,410
Foreign currency gain (loss) 56,176 (13,797)
Total other income 339,579 242,613 Close
Net loss (2,810,091) (4,379,890) Close
Other comprehensive (loss) gain:    
Foreign currency translation (15,083) 61,956
Total comprehensive loss $ (2,825,174) $ (4,317,934)
Net loss per share attributable to common stockholders, basic (in dollars per share) $ (0.67) $ (1.34)
Net loss per share attributable to common stockholders, diluted (in dollars per share) $ (0.67) $ (1.34)
Weighted-average common shares outstanding, basic (in shares) 4,198,326 3,260,484
Weighted-average common shares outstanding, diluted (in shares) 4,198,326 3,260,484